| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |